Az onkológiai ellátás egészség- gazdaságtani vonatkozásai: A teljesítményvolumen- korlát (TVK) finanszírozási hatása

Translated title of the contribution: Health economics of oncology care: Financial effect of performance volume limit (PVL)

Imre Boncz, Éva Donka-Verebes, Ferenc Oberfrank, Miklós Kásler

Research output: Contribution to journalArticle

1 Citation (Scopus)


The aim of our study is to analyze the effect of performance volume limit (PVL) on the performance indicators of acute oncology care, with special respect to the health insurance reimbursement not paid to health care providers. Data were derived from the nationwide administrative dataset of the National Health Insurance Fund Administration (OEP) covering the period of 2006-2008. We analyzed the effect of PVL according to medical specialities. We calculated the average annual reimbursement rate of DRG cost-weight with and without the application of PVL. The loss due to PVL was calculated both by monetary terms and as the % of annual revenue. The loss of medical specialities measured by monetary units (Hungarian forint, HUF) and as a percent of their revenues was the following in 2008: oncology 1327 million HUF (4.7%), cardiology 791 million HUF (3.0%), gynecology and obstetrics 772 million HUF (3.0%), internal medicine 708 million HUF (3.3%), intensive care 661 million HUF (2.5%), surgery 637 million HUF (3.2%), pediatrics 614 million HUF (3.9%), traumatology 545 million HUF (2.5%), radiotherapy 438 million HUF (3.1%). The application of performance volume limit had significantly different effect on the different medical specialities. Oncology care can be considered as one of the largest losers of the application of performance volume limit.

Original languageHungarian
Pages (from-to)35-39
Number of pages5
JournalMagyar onkologia
Issue number1
Publication statusPublished - Mar 1 2010


ASJC Scopus subject areas

  • Medicine(all)

Cite this